Home Cart Sign in  
Chemical Structure| 569-57-3 Chemical Structure| 569-57-3

Structure of Chlorotrianisene
CAS No.: 569-57-3

Chemical Structure| 569-57-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Chlorotrianisene, a synthetic and non-steroidal estrogen, is a modulator of estrogen receptor.

Synonyms: NSC 10108; tri-p-anisylchloroethylene; Rianil

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Chlorotrianisene

CAS No. :569-57-3
Formula : C23H21ClO3
M.W : 380.86
SMILES Code : Cl/C(C1=CC=C(OC)C=C1)=C(C2=CC=C(OC)C=C2)/C3=CC=C(OC)C=C3
Synonyms :
NSC 10108; tri-p-anisylchloroethylene; Rianil
MDL No. :MFCD00048044
InChI Key :BFPSDSIWYFKGBC-UHFFFAOYSA-N
Pubchem ID :11289

Safety of Chlorotrianisene

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335-H351-H361
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00834158 Hepatocellular Carcinoma Not Applicable Completed - China ... More >> Eastern Hepatobiliary Surgery Hospital Shanghai, China, 200438 Less <<
NCT02557490 Colon Cancer Liver Metastasis Phase 4 Unknown December 2017 China, Beijing ... More >> Beijing Cancer Hospital Recruiting Beijing, Beijing, China, 100142 Contact: Zhu Xu, Master    0086-10-88195476    zhux387@263.net    Principal Investigator: Zhu Xu, Master Less <<
NCT02147301 Hepatocellular Carcinoma ... More >> Chemoembolization Less << Phase 2 Enrolling by invitation - United States, California ... More >> University of California San Francisco San Francisco, California, United States, 94143 Less <<
NCT03398122 Hepatocellular Carcinoma Not Applicable Recruiting April 1, 2019 China, Tianjin ... More >> Tianjin Medical University Cancer Hospital Recruiting Tianjin, Tianjin, China, 300060 Contact: Zhi Guo, MD    13920076145    cjr.guozhi@vip.163.com    Contact: Haipeng Yu, MD    13352070835    jieruke@yahoo.com.cn    Sub-Investigator: Wenge Xing, MD Less <<
NCT01300143 Hepatocellular Carcinoma Phase 2 Active, not recruiting June 2020 France ... More >> CHU Amiens Amiens, France CHU d'Angers Angers, France CH Avignon Avignon, France Institut Sainte Catherine Avignon, France CHU de Bordeaux Bordeaux, France AP-HP Henri Mondor Créteil, France CHU Dijon Dijon, France CHD les Oudairies La Roche-sur-Yon, France CHR de Lille Hôpital Claude Huriez Lille, France CHU de Lyon Lyon, France CHU de Nancy Hôpital Brabois Nancy, France CHU Nantes Nantes, France CHR Orléans Orléans, France AP-HP Paul Brousse Villejuif Paris, France Hôpital Tenon Paris, France La Pitié-Salpétrière Paris, France CHU de Reims Reims, France Centre Eugene Marquis Rennes, France Less <<
NCT00868569 Liver Metastasis ... More >> Colorectal Cancer Less << Phase 4 Unknown December 2010 China, Shanghai ... More >> Zhongshan Hospital, Fudan University Recruiting Shanghai, Shanghai, China, 200032 Contact: jianmin xu, MD, PHD    008613501984869    xujmin@yahoo.com.cn    Principal Investigator: jianmin xu, MD, PHD Less <<
NCT01415063 Hepatocellular Carcinoma ... More >> RFA TACE Less << Phase 4 Unknown March 2014 China, Guangdong ... More >> Cancer Center, Sun Yat-set University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Min-Shan Chen, Ph.D.,M.D.    8620- 87343117    Chminsh@mail.sysu.edu.cn    Principal Investigator: Min-Shan Chen, M.D.,Ph.D. Less <<
NCT02338297 Carcinoma, Hepatocellular Phase 3 Unknown December 2017 China, Jiangsu ... More >> The First Affiliated Hospital of Nanjing Medical University Recruiting Nanjing, Jiangsu, China, 210009 Contact: Shi       shihb@njmu.edu.cn    Principal Investigator: Haibin Shi, MD, PhD.          Zhong da hospital, Southeast university Recruiting Nanjing, Jiangsu, China, 210009 Contact: Gaojun Teng, MD., PhD.    02583272121    gjteng@vip.sina.com Less <<
NCT01869088 Hepatocellular Carcinoma Phase 3 Active, not recruiting January 2018 China, Guangdong ... More >> Cancer Center Sun Yat-sen University Guangzhou, Guangdong, China Less <<
NCT02418988 Advanced Adult Hepatocellular ... More >>Carcinoma Less << Phase 2 Unknown December 2017 China, Shanxi ... More >> Xijing Hospital of the Fourth Military Medical University Recruiting Xi An, Shanxi, China, 710032 Contact: xinmin Zhou, MD Less <<
NCT01895010 Nausea Vomiti... More >>ng Metastatic Liver Cancer Less << Phase 2 Unknown December 2014 China, Shanghai ... More >> Shanghai Cancer Center Recruiting Shanghai, Shanghai, China, 200032 Contact: Xiaoyan Zhu, Dotral    +08602164175590 ext 3625    zhuxiaoyan@fudan.edu.cn    Principal Investigator: Xiaoyan Zhu, doc Less <<
NCT01480817 Hepatocellular Carcinoma Phase 2 Terminated(Difficulty of parti... More >>cipant enrollment.) Less << - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less <<
NCT02182687 Hepatocellular Carcinoma ... More >> HCC Less << Phase 2 Recruiting July 2019 United States, Massachusetts ... More >> Lahey Hospital & Medical Center Recruiting Burlington, Massachusetts, United States, 01805 Contact: Francis W Nugent, MD    781-744-8400    francis.w.nugent@lahey.org    Principal Investigator: Francis W Nugent, MD Less <<
NCT02018757 Carcinoma, Hepatocellular Phase 2 Unknown - China, Guangdong ... More >> Sun Yat-sen University Cancer Center Not yet recruiting Guangzhou, Guangdong, China Principal Investigator: Peihong Wu, MD,PHD          China, Jiangsu Zhongda Hospital Southeast University Not yet recruiting Nanjing, Jiangsu, China Contact: Gaojun Teng, MD,PhD          Principal Investigator: Gaojun Teng, MD,PhD          China, Liaoning The First Hospital of China Medical University Not yet recruiting Shenyang, Liaoning, China, 110001 Principal Investigator: Haibo Shao, MD,PHD          China, Shaanxi Xijing Hospital,Fourth Military Medical University Not yet recruiting Xi'an, Shaanxi, China Principal Investigator: Guohong Han, MD,PhD          China Zhongshan Hospital Fudan University Not yet recruiting Shanghai, China Principal Investigator: Jianhua Wang, MD,PHD Less <<
NCT00539253 - Completed - -
NCT02956772 Primary Hepatocellular Carcino... More >>ma Less << Phase 2 Not yet recruiting November 2020 China, Guizhou ... More >> Guizhou Cancer Hospital Not yet recruiting Guiyang, Guizhou, China Contact: Shi Zhou, Dr.       258600801@qq.com    Guizhou Province Tumor Hospital Not yet recruiting Guiyang, Guizhou, China Contact: Junxiang Li, Dr.       258600801@qq.com    China, Hunan Hunan Provincial People's Hospital Not yet recruiting Changsha, Hunan, China, 410001 Contact: Hua Xiang, Dr.    +86-13667367061       Contact: Lin Long, Dr.    +86-13507476175    doclongll@163.com    Hunan Cancer Hospital Not yet recruiting Changsha, Hunan, China Contact: Guowen LI, Dr.       liguowen@hnszlyy.com    Xiangya Hospital Central South University Not yet recruiting Changsha, Hunan, China Contact: Chunhui Zhou, Dr.       zhouchunhui2016@163.com    The First Affiliated Hospital of University of South China Not yet recruiting Hengyang, Hunan, China Contact: Youhua Wu, Dr.       330270372@qq.com    China, Jiangsu Jiangsu Province Hospital Not yet recruiting Nanjing, Jiangsu, China Contact: Zhen-Qiang Yang, Dr.       ntdoctoryang@hotmail.com    China, Xinjiang Xinjiang Medical University Cancer Hospital Not yet recruiting Urumqi, Xinjiang, China Contact: Shufa Yang, Dr.       yangshufa2013@sina.com    China, Yunnan The Tumor Hospital of Yunnan Province Not yet recruiting Kunming, Yunnan, China Contact: Ming Huang, Dr.       huangming4328@sina.com Less <<
NCT03730675 Hepatocellular Carcinoma ... More >> Portal Vein Tumor Thrombosis Less << Not Applicable Not yet recruiting November 2021 -
NCT00539253 Hepatocellular Carcinoma Not Applicable Completed - United States, Maryland ... More >> The Johns Hopkins Hospital Baltimore, Maryland, United States, 21287 Less <<
NCT01393093 Carcinoma, Hepatocellular Not Applicable Unknown December 2018 China, Tianjin ... More >> Tianjin Medical University Cancer Hospital Recruiting Tianjin, Tianjin, China, 300060 Contact: Zhi Guo, MD    13920076145    cjr.guozhi@vip.163.com    Contact: Haipeng Yu, MD    13352070835    jieruke@yahoo.com.cn    Sub-Investigator: Wenge Xing, MD Less <<
NCT02436902 Hepatocellular Carcinoma Phase 3 Recruiting August 2019 China, Guangxi ... More >> Department of Hepatobilliary Surgery, Affiliated Tumor of Guangxi University Recruiting Nanning, Guangxi, China, 530021 Contact: Bang-De Xiang, MD,PhD    86-771-5330855    xiangbangde@163.com Less <<
NCT03397654 Primary Liver Carcinoma Phase 1 Phase 2 Recruiting December 31, 2019 United Kingdom ... More >> Imperial College Healthcare NHS Trust Recruiting London, United Kingdom Contact: Rohini Sharma, MD          Principal Investigator: Rohini Sharma, MD Less <<
NCT00618384 Hepatocellular Carcinoma Phase 2 Terminated - Germany ... More >> Universitätsklinikum Tübingen Innere Medizin I Tübingen, BW, Germany, 72076 Medizinische Universitätsklinik Ulm Innere Medizin I Ulm, BW, Germany, 89081 Klinikum der Universität Großhardern Muenchen, BY, Germany, 81377 Klinikum der Johann-Goethe-Universität Frankfurt, HE, Germany, 60590 Universitätsklinikum Hamburg-Eppendorf Zentrum für Innere Medizin Hamburg, HH, Germany, 20246 Johannes-Gutenberg-Universität Medizinische Klinik Mainz, RP, Germany, 55131 Less <<
NCT02487017 Hepatocellular Carcinoma ... More >> Neoplasms Digestive System Neoplasms Less << Phase 2 Unknown December 2018 China, Shandong ... More >> Yantai City Hospital for Infectious Diseases Recruiting Yantai, Shandong, China, 264000 Contact: Xiangzhong Liu, Professor    0535-6606193 Less <<
NCT00576199 - Completed - -
NCT01798160 Hepatocellular Carcinoma Phase 4 Completed - -
NCT03642561 Hepatocellular Carcinoma Phase 2 Phase 3 Not yet recruiting August 2023 -
NCT00921531 Hepatocellular Carcinoma Phase 3 Unknown April 2013 China, Shanghai ... More >> Liver Cancer Institute Recruiting Shanghai, Shanghai, China, 200032 Contact: Zheng-Gang Ren, Ph.D    0086-021-64041990 ext 2137    ren.zhenggang@zs-hospital.sh.cn    Contact: Lan Zhang, Master    0086-021-64041990 ext 2171    zhang.lan@zs-hospital.sh.cn    Principal Investigator: Zheng-Gang Ren, Ph.D          Sub-Investigator: Jubo Zhang, PhD Less <<
NCT00576199 Liver Cancer Phase 2 Completed - Hong Kong ... More >> Hong Kong, Hong Kong, 0 Hong Kong, Hong Kong, 852 Hong Kong, Hong Kong Less <<
NCT02004210 Hepatocellular Carcinoma Phase 3 Withdrawn(No participants were... More >> enrolled.) Less << April 2018 Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of Less <<
NCT02971345 Hepatocellular Carcinoma ... More >> Portal Vein Tumor Thrombus Less << Phase 3 Recruiting June 2019 China, Shanghai ... More >> Department of Interventional Radiology, Zhongshan Hospital, Fudan University Recruiting Shanghai, Shanghai, China, 200032 Contact: Jianjun Luo, MD       zhangzihan0217@126.com    Principal Investigator: Zhinping Yan, MD          Sub-Investigator: Jianjun Luo, MD Less <<
NCT00467974 Hepatocellular Carcinoma Phase 3 Completed - Hong Kong ... More >> Department of Clinical Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong Hong Kong, Hong Kong Department of Diagnostic Radiology and Organ Imaging, Prince of Wales Hospital, The Chinese University of Hong Kong Hong Kong, Hong Kong Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong Hong Kong, Hong Kong Less <<
NCT02631499 Carcinoma, Hepatocellular ... More >> Neoplastic Cells, Circulating Less << Phase 4 Not yet recruiting December 2019 China, Guangdong ... More >> Sun Yat-Sen University Cancer Center Not yet recruiting Guangzhou, Guangdong, China, 510000 China, Jiangsu Nantong Tumor Hospital Not yet recruiting Nantong, Jiangsu, China, 226000 The First Affiliated Hospital of Soochow University Not yet recruiting Soochow, Jiangsu, China, 215000 China, Shanghai Eastern Hepatobiliary Surgery Hospital, Second Military Medical University Not yet recruiting Shanghai, Shanghai, China, 200000 Xinhua Hospital, Affliated with Shanghai Jiao Tong University, School of Medicine Shanghai, Shanghai, China, 200000 Zhongshan hospital, Fudan University Not yet recruiting Shanghai, Shanghai, China, 200000 Less <<
NCT03326375 HepatoCellular Carcinoma Not Applicable Recruiting March 2021 Korea, Republic of ... More >> Gangneung Asan Hospital Recruiting Wŏnju, Gangwondo, Korea, Republic of, 25440 Contact: Baek Gyu Jun, M.D    82-10-5674-0712    backyou78@hanmail.net    Contact: Gan Jin Cheon, M.D Ph.D.    82-33-610-3018    1000@gnah.co.kr Less <<
NCT03652467 Hepatocellular Carcinoma Non-r... More >>esectable Less << Phase 1 Not yet recruiting December 31, 2023 -
NCT03145558 Carcinoma, Hepatocellular Phase 2 Recruiting October 31, 2021 United States, California ... More >> University of California, Irvine Recruiting Irvine, California, United States, 92868 Contact: Jennifer D Berg    714-456-7687    jdberg@uci.edu    United States, Oregon Oregon Health Science University Recruiting Portland, Oregon, United States, 97239 United States, Wisconsin Medical College of Wisconsin Recruiting Milwaukee, Wisconsin, United States, 53226 Less <<
NCT00908752 Hepatocellular Carcinoma Phase 3 Completed - -
NCT03572582 Carcinoma, Hepatocellular ... More >> Hepatic Carcinoma Hepatocellular Cancer Less << Phase 2 Recruiting September 2022 Germany ... More >> Medizinische Hochschule Hannover, Klinik für Gastroenterologie, Hepatologie & Endokrinologie Recruiting Hannover, Germany, 30625 Contact: Arndt Vogel, Prof.Dr.       Vogel.Arndt@mh-hannover.de Less <<
NCT02507765 Child-Pugh Class A ... More >> Child-Pugh Class B Stage IIIA Hepatocellular Carcinoma Stage IIIB Hepatocellular Carcinoma Stage IIIC Hepatocellular Carcinoma Stage IVA Hepatocellular Carcinoma Stage IVB Hepatocellular Carcinoma Less << Not Applicable Recruiting October 31, 2018 United States, Ohio ... More >> Ohio State University Comprehensive Cancer Center Recruiting Columbus, Ohio, United States, 43210 Contact: Terence M. Williams, MD, PhD    614-293-5557    terence.williams@osumc.edu    Principal Investigator: Terence M. Williams, MD, PhD Less <<
NCT00746655 Hepatocellular Carcinoma Not Applicable Withdrawn(Unable to recruit) - United States, Pennsylvania ... More >> UPMC Presbyterian/Montifore Pittsburgh, Pennsylvania, United States, 15213 Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15232 UPMC Cancer Pavilion Pittsburgh, Pennsylvania, United States, 15232 UPMC Shadyside Radiation Oncology Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT02537158 Hepatocellular Carcinoma Not Applicable Unknown July 2018 China ... More >> Cancer Hospital and Institute, Chinese Academy of Medical Sciences Recruiting Bei jing, China, 100026 Contact: Xinyu Bi, Doctor    86-13911792177    beexy1971@163.com Less <<
NCT02504983 Hepatocellular Carcinoma Phase 4 Unknown July 2018 Taiwan ... More >> Chang Gung Memorial Hospital Recruiting Taoyuan, Taiwan Contact: Chau-Ting Yeh, MD/PhD    +886-3-3281200 ext 8125    chautingy@gmail.com Less <<
NCT00825474 Hepatocellular Carcinoma Not Applicable Completed - China, Shanghai ... More >> Eastern Hepatobiliary Surgery Hospital Shanghai, Shanghai, China Less <<
NCT00554905 Hepatocellular Carcinoma ... More >> Liver Cancer Less << Phase 4 Unknown June 2009 China, Guangdong ... More >> Department of Hepatobilliary Surgery, Cancer Center, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Min-Shan Chen, Doctor    86-20-87343117 ext 86-20-87343117    Chminsh@mail.sysu.edu.cn    Principal Investigator: Min-Shan Chen, Doctor Less <<
NCT01798147 Intrahepatic Cholangiocellular... More >> Carcinoma Less << Phase 2 Recruiting June 2018 Germany ... More >> Department of Diagnostic and Interventional Radiology Recruiting Mainz, Germany, 55131 Contact: Roman Kloeckner, MD    ++49613117 ext 2019    roman.kloeckner@unimedizin-mainz.de Less <<
NCT00990860 Hepatocellular Carcinoma Phase 2 Unknown - Taiwan ... More >> E-Da hospital Kaohsiung, Taiwan Veterans General Hospital- Kaochiung Kaoshiung, Taiwan Veterans General Hospital- Taichung Taichung, Taiwan National Cheng Kung University Hospital Tainan, Taiwan Mackay Memorial Hospital Taipei, Taiwan Tri- Service General Hospital Taipei, Taiwan Veterans General Hospital- Taipei Taipei, Taiwan Chang-Gung Memorial Hospital- LinKou TaoYuan Hsien, Taiwan Less <<
NCT01861912 Carcinoma, Hepatocellular Phase 2 Phase 3 Unknown December 2016 -
NCT00518557 Hepatocellular Carcinoma Not Applicable Unknown December 2009 China, Jiangsu ... More >> Department of Interventional Radiology, Zhongda Hospital, Southeast University Recruiting Nanjing, Jiangsu, China, 210009 Contact: Xiao-Hui Chen, MD    +86 25 83272121    noriko0706@sohu.com    Contact: Gang Deng, MD    +86 25 83272118    dmm1996@sina.com    Sub-Investigator: Gang Deng, MD, Ph.D          Sub-Investigator: Shi-Cheng He, MD          Sub-Investigator: Jin-He Guo, MD Less <<
NCT03608878 Hepatocellular Carcinoma Phase 2 Not yet recruiting December 31, 2020 Taiwan ... More >> Linkou Chang Gung Memorial Hospital Not yet recruiting Taoyuan City, Taoyuan, Taiwan, 333 Contact: Chau-Ting Yeh, MD    886 3 3281200 ext 8121    cgaytubg@adm.cgmh.org.tw Less <<
NCT03277716 Hepatocellular Carcinoma Non-r... More >>esectable Transarterial Chemoembolization Microwave Ablation Less << Not Applicable Recruiting December 30, 2021 China, Beijing ... More >> Cancer Institute &Hospital, Chinese Academy of Medical Sciences Not yet recruiting Beijing, Beijing, China, 100021 Contact: Xiao Li, M.D          China, Fujian The First Affiliated Hospital of Fujian Medical University Recruiting Fuzhou, Fujian, China, 350005 Contact: Zhenyu Lin, M.D.          The tumor hospital of Fujian Province Not yet recruiting Fuzhou, Fujian, China, 350014 Contact: Hailan Lin, M.D          China, Guangdong the First Affiliated Hospital of SunYat-senUniversity Not yet recruiting Guangzhou, Guangdong, China, 510080 Contact: Jiaping Li, M.D          Shenzhen People's Hospital Recruiting Shenzhen, Guangdong, China, 518020 Contact: Yanfang Zhang, M.D.          Peking University Hospital of Shenzhen Recruiting Shenzhen, Guangdong, China, 518036 Contact: Junhui Chen, M.D.          China, Shandong The Second Affiliated Hospital of Shandong University Recruiting Jinan, Shandong, China, 250000 Contact: Yuliang Li, M.D          Shandong Province Hospital Recruiting Jinan, Shandong, China, 250014 Contact: Xin Ye, M.D          the Affiliated Hospital of Medical College Qingdao University Recruiting Qingdao, Shandong, China, 26555 Contact: Zixiang Li, M.D          China, Zhejiang The First Affiliated Hospital of Zhejiang University Not yet recruiting Hangzhou, Zhejiang, China, 310003 Contact: Junhui Sun, M.D. Less <<
NCT02032368 Circulating Tumor Cell; ... More >> Hepatocellular Carcinoma Less << Not Applicable Completed - China, Guangdong ... More >> Department of Interventional Radiology; Cancer Center; Guangdong General Hospital Guangzhou, Guangdong, China Less <<
NCT01170104 Hepatocellular Carcinoma Phase 2 Unknown June 2013 Korea, Republic of ... More >> Chung-Ang University Hospital Recruiting Dongjak, Seoul, Korea, Republic of, 156-755 Contact: Joung-Soon Jang, M.D.    82-2-6299-1427    alsaba@daum.net    Contact: In Gyu Hwang, M.D.    82-2-748-9786    higyu72@yahoo.co.kr    Principal Investigator: Joung-Soon Jang, M.D.          Sub-Investigator: Hyung Joon Kim, M.D.          Sub-Investigator: Hyun Woong Lee, M.D.          Sub-Investigator: In Gyu Hwang, M.D. Less <<
NCT02301091 Hepatocellular Carcinoma Phase 3 Recruiting October 2019 China, Guangdong ... More >> Minimally Invasive Interventional Division, Medical Imaging Center, Sun Yat-sen University Cancer Center, Recruiting Guangzhou, Guangdong, China, 500060 Contact: Ming Zhao, doctor    +86 020 87343272    zhaoming@sysucc.org.cn Less <<
NCT03314532 Surgical Resection ... More >> HCC Less << Not Applicable Not yet recruiting December 31, 2022 China, Zhejiang ... More >> The Second Affiliated Hospital Zhejiang University School of Medicine Not yet recruiting Hanzhou, Zhejiang, China, 310009 Contact: Jiang-tao Li, MD    86-13666651245    zjulijiangtao@163.com Less <<
NCT02921139 Hepatocellular Carcinoma(HCC) Not Applicable Recruiting November 2021 Taiwan ... More >> Dalin Tzu Chi Hospital Recruiting Chiayi City, Taiwan, 62247 Contact: Liang-Cheng Chen, MD    +886-5-2648000 ext 71056    atonsobek@yahoo.com.tw    Principal Investigator: Shih-Kai Hung, PhD Less <<
NCT01217034 Hepatocellular Carcinoma ... More >> Unresectable Hepatocellular Carcinoma Carcinoma, Hepatocellular Liver Neoplasm Less << Phase 2 Active, not recruiting March 2018 Japan ... More >> Kinki University Hospital Osaka-Sayama, Osaka, Japan, 589-8511 Less <<
NCT02728219 Recurrent Hepatocellular Carci... More >>noma Less << Not Applicable Completed - China, Shanghai ... More >> Eastern hepatobilliary surgery hospital Shanghai, Shanghai, China, 200438 Less <<
NCT01556815 PHENYTOIN/SORAFENIB [VA Drug I... More >>nteraction] Liver Neoplasms Carcinoma, Hepatocellular Digestive System Neoplasms Neoplasms by Site Liver Diseases Adenocarcinoma Carcinoma Neoplasms, Glandular and Epithelial Neoplasms by Histologic Type DOXORUBICIN/TRASTUZUMAB [VA Drug Interaction] HBV Less << Phase 2 Unknown May 2015 China, Shandong ... More >> Shandong Cancer Hospital and Institute Not yet recruiting Jinan, Shandong, China, 250117 Contact: Wenbo Shao, MD, Ph D    +8653167626412    shaowenbomd@gmail.com    Principal Investigator: Jinlong Song, MD          Sub-Investigator: Wenbo Shao, MD, Ph D Less <<
NCT03066557 Hepatocellular Carcinoma Not Applicable Not yet recruiting December 31, 2018 -
NCT02788526 Carcinoma, Hepatocellular Phase 3 Completed - China, Guangdong ... More >> SUN YAT-SEN University Cancer Center Guangzhou, Guangdong, China, 510060 Less <<
NCT01721941 Hepatocellular Carcinoma Phase 1 Unknown December 2016 United States, California ... More >> Scripps Clinic Not yet recruiting La Jolla, California, United States, 92037 Contact: Alain Perez    858-554-8937    Perez.Alain@scrippshealth.org    Principal Investigator: Darren S Sigal, M.D. Less <<
NCT01020812 Carcinoma, Hepatocellular ... More >> Hepatobiliary Neoplasm Liver Carcinoma Less << Phase 1 Phase 2 Terminated(enrollment was too ... More >>low) Less << - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT02006030 Unresectable Hepatocellular Ca... More >>rcinoma Less << Phase 2 Completed - Taiwan ... More >> CMUH Taichung City, Taiwan TP-VGH Taipei City, Taiwan National Taiwan University Hospital Taipei, Taiwan CGMH-LK Taoyuan, Taiwan Less <<
NCT01020812 - Terminated(enrollment was too ... More >>low) Less << - -
NCT02702323 Hepatocellular Carcinoma ... More >> Pulmonary Metastasis Less << Phase 2 Phase 3 Not yet recruiting March 2019 -
NCT02958163 Liver Neoplasms ... More >> Hepatocellular Cancer Less << Phase 2 Terminated(lack of recruitment... More >>) Less << - Belgium ... More >> Hôpital de JOLIMONT Jolimont, Hainaut, Belgium, 7100 Centre Hospitalier Universitaire/CHC Saint Joseph Liege, Liège, Belgium, 4000 Cliniques Universitaires Saint Luc Brussels, Woluwé Saint Lambert, Belgium, 1200 Institut Jules Bordet/Hôpital Erasme Brussels, Belgium, 1000 Clinique et Maternité Sainte Elisabeth/CHU Mont Godinne Namur, Belgium, 5000 Less <<
NCT03636620 Hepatocellular Carcinoma Phase 3 Completed - China ... More >> liver cancer institute ,Fudan University Shanghai, China, 200032 Less <<
NCT00936689 Carcinoma, Hepatocellular Phase 4 Completed - Italy ... More >> Ospedali Riuniti di Bergamo Bergamo, BG, Italy, 24121 Azienda Ospedaliera Universitaria Pisana - Stabilimento di Cisanello Pisa, PI, Italy, 56100 Azienda Ospadaliera Universitaria S.Giovanni Battista - Molinette Torino, TO, Italy, 10121 Azienda Ospedaliera Universitaria S.Maria della Misericordia Udine, UD, Italy, 33100 Azienda Ospedaliero-Universitaria, Policlinico S.Orsola-Malpighi Bologna, Italy, 40138 Less <<
NCT03079778 Hepatocellular Carcinoma Not Applicable Not yet recruiting August 2023 -
NCT00576056 - Terminated(Bayer Healthcare is... More >> no supplying the study drug) Less << - -
NCT00576056 Carcinoma, Hepatocellular Phase 2 Terminated(Bayer Healthcare is... More >> no supplying the study drug) Less << - United States, Pennsylvania ... More >> University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT01933945 - Completed - -
NCT00556803 Hepatocellular Carcinoma ... More >> Liver Cancer Less << Phase 4 Unknown June 2010 China, Guangdong ... More >> Department of Hepatobiliary Surgery, Cancer Center, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Min-Shan Chen, M.D., Ph.D.    86-20-87343117    Chminsh@mail.sysu.edu.cn Less <<
NCT01360255 - Completed - Germany ... More >> University Medical Center Freiburg Freiburg, Baden-Württemberg, Germany, 79106 Less <<
NCT00919009 Carcinoma, Hepatocellular Phase 2 Completed - Korea, Republic of ... More >> National Cancer Center Seoul, Korea, Republic of Less <<
NCT02070419 Adult Primary Hepatocellular C... More >>arcinoma Recurrent Adult Primary Liver Cancer Stage I Adult Primary Liver Cancer Stage II Adult Primary Liver Cancer Stage IIIA Adult Primary Liver Cancer Less << Phase 2 Withdrawn(Principal Investigat... More >>or left institution) Less << - -
NCT02435953 Hepatocellular Carcinoma ... More >> Chemoembolization, Therapeutic Ablation Techniques, RFA Less << Phase 4 Recruiting - China, Guangdong ... More >> Minimally Invasive Interventional Division, Medical Imaging Center, Sun Yat-sen University Cancer Center, Recruiting Guangzhou, Guangdong, China, 500060 Contact: Ming Zhao, doctor    +86 020 87343272    zhaoming@sysucc.org.cn    Contact: Tao Pan, doctor    +86 020 87343271    pantao0909@hotmail.com Less <<
NCT03285867 - Not yet recruiting December 2021 -
NCT01223196 Type 2 Diabetes Phase 4 Completed - United States, Texas ... More >> Bartter Research Unit , ALM VA Hospital San Antonio, Texas, United States, 78229 Less <<
NCT02670122 - Active, not recruiting October 2018 Spain ... More >> Fundación Jiménez Díaz Madrid, Spain, 28040 Less <<
NCT01605734 PHENYTOIN/SORAFENIB [VA Drug I... More >>nteraction] Carcinoma, Hepatocellular Less << Phase 2 Unknown December 2015 China, Shandong ... More >> Shandong Medical Imaging Research Institute Not yet recruiting Jinan, Shandong, China, 250021 Contact: Jun Tang, MD    +8613964031909    tangjun7925032@163.com    Principal Investigator: Jun Tang, MD          Qilu Hospital of Shandong University Not yet recruiting Jinan, Shandong, China, 250114 Contact: Caixia Li, MD    +8613505312972    Lilyshanda88@hotmail.com    Principal Investigator: Caixia Li, MD          Shandong Cancer Hospital and Institute Jinan, Shandong, China, 250117 the Affiliated Hospital of Medical College Qingdao University Not yet recruiting Qingdao, Shandong, China, 266003 Contact: Zixiang Li, MD    +8618669739263    zixiangli@yahoo.com.cn    Principal Investigator: Zixiang Li, MD          Yantai Yuhuangding Hospital Not yet recruiting Yantai, Shandong, China, 264000 Contact: Yanbo Zheng, MD    +8613805356068    13805356068@163.com    Principal Investigator: Yanbo Zheng Less <<
NCT02794337 Carcinoma, Hepatocellular Phase 2 Phase 3 Recruiting January 2022 India ... More >> Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre Recruiting Navi Mumbai, Maharashtra, India, 410210 Contact: Supriya Chopra, MD,DNB    022-27405000 ext 5510    schopra@actrec.gov.in    Advanced Centre of Treatment Research and Education In Cancer,Tata Memorial Centre Recruiting Navi Mumbai, Maharashtra, India, 410210 Contact: Dr Supriya Chopra, MD    91-22-27405000 ext 5491    schopra@actrec.gov.in    Principal Investigator: Supriya Chopra, MD Less <<
NCT03591705 Unresectable Hepatocellular Ca... More >>rcinoma Less << Not Applicable Recruiting December 30, 2020 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Yunfei Yuan    862087343118    yuanyf@mail.sysu.edu.cn Less <<
NCT02715492 HCC Phase 3 Not yet recruiting December 2022 Egypt ... More >> Tanta university - faculty of medicine Tanta, Egypt Less <<
NCT01247298 - Completed - -
NCT02630108 Carcinoma, Hepatocellular Phase 3 Unknown April 2018 China, Shanghai ... More >> Department of Interventional Radiology, Zhongshan Hospital, Fudan University Recruiting Shanghai, Shanghai, China, 200032 Contact: Jianhua Wang, MD    +8613611749557    wang.jianhua@zs-hospital.sh.cn    Contact: Rong Liu, MD    +8613681971563    liu.rong@zs-hospital.sh.cn    Principal Investigator: Jianhua Wang, MD          Sub-Investigator: Rong Liu, MD Less <<
NCT01833286 Hepatocellular Carcinoma ... More >> Surgery Ablation Less << Phase 3 Not yet recruiting July 2019 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Not yet recruiting Guangzhou, Guangdong, China, 510060 Contact: minshan chen, M.D.    8620-87343117 ext 8620-87343117    chminsh@mail.sysu.edu.cn    Contact: yaojun zhang, M.D.    8620-87343121    zhyaojun@mail.sysu.edu.cn    Principal Investigator: minshan chen, M.D. Less <<
NCT02529761 Hepatocellular Carcinoma Not Applicable Unknown October 2018 China, Shaanxi ... More >> Xijing Hospital of digestive disease, Fourth Military Medical University Recruiting Xi'an, Shaanxi, China, 710032 Contact: Han       hangh@fmmu.edu.cn    Principal Investigator: Guohong Han, MD,Ph.D Less <<
NCT02311205 Hepatocellular Carcinoma ... More >> Metastasis Less << Phase 2 Active, not recruiting June 2018 Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of Less <<
NCT01393197 Carcinoma, Hepatocellular Not Applicable Unknown December 2016 China, Tianjin ... More >> Tianjin Medical University Cancer Institute and Hospital Recruiting Tianjin, Tianjin, China, 300060 Contact: Zhi Guo, MD    13920076145    cjr.guozhi@vip.163.com    Contact: Haipeng Yu, MD    13352070835    jieruke@yahoo.com.cn Less <<
NCT02290977 Hepatocellular Carcinoma ... More >> Portal Vein Tumor Thrombosis Less << Phase 2 Unknown April 2016 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of, 135-710 Contact: Yong Han Paik, MD, PhD       yh.paik@samsung.com    Principal Investigator: Yong-Han Paik, MD, PhD          Sub-Investigator: Hee Chul Park, MD, PhD          Sub-Investigator: Ju-Yeon Cho, MD          Sub-Investigator: Jeong Il Yu, MD Less <<
NCT01223196 - Completed - -
NCT03086564 Hepatocellular Carcinoma Phase 1 Phase 2 Recruiting May 1, 2020 China, Guangdong ... More >> The Third Affiliated Hospital of Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510630 Contact: Yurong Gu, Doctor    8620-85252702    guyr163@163.com    Contact: Yuehua Huang, Doctor    86-18922103516    huangyh53@sysu.edu.cn Less <<
NCT01247298 Hepatocellular Carcinoma (HCC) Early Phase 1 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35233 Less <<
NCT03510416 Hepatocellular Carcinoma Refra... More >>ctory to Transcatheter Arterial Chemoembolization Less << Phase 2 Not yet recruiting December 31, 2019 -
NCT00960518 Hepatitis B Virus ... More >> Hepatocellular Carcinoma Less << Phase 2 Unknown August 2015 China, Heilongjiang ... More >> The Fourth Affiliated Hospital of Haerbin Medical University Recruiting Ha'er'bin, Heilongjiang, China, 150001 Contact: Baozhong Shen, MD    +86-451-82576888    drbaozhong.shen@gmail.com    Principal Investigator: Baozhong Shen, MD          China, Shanghai Shanghai 10th Hospital of Tongji University Recruiting Shanghai, Shanghai, China, 200025 Contact: Maoquan Li, MD, PhD    +86-21-6630058    drmaoquan.li@gmail.com    Principal Investigator: Maoquan Li, MD, PhD Less <<
NCT02748161 Hepatocellular Carcinoma Not Applicable Terminated(Low enrollment) - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States United States, Arizona University of Arizona Phoenix, Arizona, United States United States, California UCLA Los Angeles, California, United States USC Los Angeles, California, United States United States, Colorado Radiology Imaging Associates Denver, Colorado, United States United States, District of Columbia Georgetown University Washington, District of Columbia, United States United States, Maryland University of Maryland Baltimore, Maryland, United States United States, New York New York University New York, New York, United States United States, Ohio Cleveland Clinical Foundation Cleveland, Ohio, United States University Hospitals of Cleveland Cleveland, Ohio, United States United States, Utah University of Utah Salt Lake City, Utah, United States Less <<
NCT01833299 Hepatocellular Carcinoma ... More >> Face Cancer Less << Phase 4 Unknown December 2014 China ... More >> Cancer Centre of Sun Yat-Sen University Recruiting Guangzhou, China, 510060 Contact: min-shan chen, M.D.,Ph.D.    87343117    Chminsh@mail.sysu.edu.cn    Principal Investigator: min-shan chen, M.D.,Ph.D. Less <<
NCT03211598 Hepatocellular Carcinoma Not Applicable Recruiting December 2019 United States, District of Col... More >>umbia Medstar Georgetown University Hospital Recruiting Washington, District of Columbia, United States, 20007 Contact: Alexander Y Kim, MD    202-444-5478 ext 2    Alexander.Y.Kim@gunet.georgetown.edu Less <<
NCT02588755 Intrahepatic Cholangiocarcinom... More >>a Less << Not Applicable Unknown December 2017 China, Shanghai ... More >> Eastern hepatobilliary surgery hospital Recruiting Shanghai, Shanghai, China, 200438 Contact: Shen Feng, MD    0086-021-25070805    shenfengdfgd@yahoo.com.cn    Contact: Yong Xia, Doctor    86-021-81875495       Principal Investigator: Shen Feng, MD Less <<
NCT02304445 Carcinoma, Hepatocellular Not Applicable Withdrawn(Necessary equipment ... More >>could not be obtained.) Less << November 2017 -
NCT02323360 Hepatocellular Carcinoma Phase 3 Unknown May 2018 Italy ... More >> Humanitas Research Hospital Recruiting Rozzano, Milan, Italy, 20089 Contact: Marta Scorsetti, MD PhD    +390282248524    marta.scorsetti@humanitas.it    Principal Investigator: Marta Scorsetti, MD PhD Less <<
NCT03116984 Hepatocellular Carcinoma Phase 3 Recruiting December 31, 2020 China, Shanghai ... More >> 180 Fenglin Road Recruiting Shanghai, Shanghai, China, 200032 Contact: Yixing Chen, Phd    86-13916056575    chen.yixing@zs-hospital.sh.cn    Principal Investigator: Zhaochong Zeng, Professor          Sub-Investigator: Yixing Chen, doctor Less <<
NCT03575806 Hepatocellular Carcinoma ... More >> Malignant Neoplasm Less << Phase 2 Recruiting January 9, 2020 China, Beijing ... More >> Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting Beijing, Beijing, China, 100021 Contact: Hong Zhao    +86-13381106850 Less <<
NCT02150317 Advanced Hepatocellular Carcin... More >>oma Less << Not Applicable Unknown December 2016 China, Shanghai ... More >> Eastern Hepatobiliary Surgery Hospital Recruiting Shanghai, Shanghai, China, 200438 Contact: Ai-jun Li, M.D.    0086-021-81875531    yinlei409@hotmail.com    Contact: Lei Yin, M.D.    0086-021-81875532    dermatology2008@126.com Less <<
NCT00820157 Hepatocellular Carcinoma Not Applicable Completed - China, Shanghai ... More >> Eastern Hepatobiliary Surgery Hospital Shanghai, Shanghai, China, 200438 Less <<
NCT03322280 Hepatocellular Carcinoma ... More >> Portal Vein Occlusion Tumor Thrombus Less << Not Applicable Enrolling by invitation June 30, 2022 China, Guangdong ... More >> The 2nd Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China, 510260 Less <<
NCT01850667 Hepatocellular Carcinoma Phase 2 Unknown April 2017 Korea, Republic of ... More >> Inje University Haeundae Paik Hospital Busan, Korea, Republic of, 612-896 Dongnam Institute of Radiological & Medical Sciences Busan, Korea, Republic of Soon Chun Hyang University Hospital Cheonan Cheonan, Korea, Republic of Catholic University Incheon St. Mary's Hospital Incheon, Korea, Republic of Inha University Hospital Incheon, Korea, Republic of Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences Seoul, Korea, Republic of, 139-706 Soon Chun Hyang University Hospital Seoul Seoul, Korea, Republic of Less <<
NCT02470533 Liver Neoplasms Phase 2 Recruiting April 2020 Belgium ... More >> UH Antwerp Recruiting Antwerp, Belgium Contact: Thomas Vanwolleghem, MD PhD          Contact: Reinhilde Weytjens, MD PhD          Principal Investigator: Thomas Vanwolleghem, MD PhD          Sub-Investigator: Reinhilde Weytjens, MD PhD          Sub-Investigator: Olivier d'Archambeau, MD PhD          UH Leuven Recruiting Leuven, Belgium Contact: Chris Verslype, Prof          Contact: Karin Haustermans, Prof          Principal Investigator: Chris Verslype, Prof          Sub-Investigator: Karin Haustermans, Prof          France UH Lille Recruiting Lille, France Contact: Stephane Cattan, MD PhD          Contact: Xavier Mirabell, MD PhD          Principal Investigator: Stephane Cattan, MD PhD          Sub-Investigator: Xavier Mirabell, MD PhD          Netherlands Erasmus MC Recruiting Rotterdam, ZH, Netherlands Contact: Alejandra Mendez Romero, MD PhD          Contact: Adriaan Moelker, MD PhD          Principal Investigator: Alejandra Mendez Romero          Sub-Investigator: Adriaan Moelker          AMC Recruiting Amsterdam, Netherlands Contact: Henrike Westerveld, MD PhD          Contact: Otto van Delden, Prof          Principal Investigator: Henrike Westerveld, MD PhD          Sub-Investigator: Otto van Delden, Prof          VU MC Recruiting Amsterdam, Netherlands Contact: Niels Haasbeek, MD PhD          Contact: Martijn Meijerink, MD PhD          Principal Investigator: Niels Haasbeek, MD PhD          Sub-Investigator: Martijn Meijerink, MD PhD          LUMC Recruiting Leiden, Netherlands Contact: Mark Burgmans, MD PhD          Contact: Mieneke Coenraad, MD PhD          Principal Investigator: Mark Burgmans, MD PhD          Sub-Investigator: Mieneke Coenraad, MD PhD          Sub-Investigator: Karen Neelis, MD PhD          Maastro Recruiting Maastricht, Netherlands Contact: Jeroen Buijsen, MD PhD          Principal Investigator: Jeroen Buijsen, MD PhD          UMC Maastricht Recruiting Maastricht, Netherlands Contact: Judith de Vos-Geelen, MD PhD          Contact: Peter Jansen, Prof          Principal Investigator: Judith de Vos-Geelen, MD PhD          Sub-Investigator: Peter Jansen, Prof          UMC St Radboud Recruiting Nijmegen, Netherlands Contact: Eric Tjwa, MD PhD          Contact: Sjoerd Jenniskens, MD PhD          Principal Investigator: Eric Tjwa, MD PhD          Sub-Investigator: Sjoerd Jenniskens, MD PhD          Sub-Investigator: Petra Braam, MD PhD          UMC Utrecht Recruiting Utrecht, Netherlands Contact: Marco van Vulpen, MD PhD          Contact: Karel van Erpecum, MD PhD          Principal Investigator: Marco van Vulpen, MD PhD          Principal Investigator: Karel van Erpecum, MD PhD Less <<
NCT01829035 Advanced Adult Hepatocellular ... More >>Carcinoma Less << Phase 3 Completed - Korea, Republic of ... More >> National Cancer Center, Korea Seoul, Korea, Republic of Less <<
NCT00932438 Colon Cancer With Metastases t... More >>o the Liver Less << Phase 1 Phase 2 Completed - United States, Alabama ... More >> Clearview Cancer Center Huntsville, Alabama, United States, 35805 United States, California Radiology Associates of Sacramento/Sutter Cancer Center Sacramento, California, United States, 95816 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 Northside Hospital/GA Cancer Specialists Atlanta, Georgia, United States, 30342 United States, Kentucky University of Louisville Louisville, Kentucky, United States, 40202 United States, Mississippi Hematology and Oncology Assoc. at Bridgeport Tupelo, Mississippi, United States, 38801 United States, Missouri Washington University/Alvin J. Siteman Cancer Center St. Louis, Missouri, United States, 63110 United States, Oregon Providence Portland Medical Center/Providence Cancer Center Portland, Oregon, United States, 97213 United States, Wisconsin Froedtert Memorial Lutheran Hospital Milwaukee, Wisconsin, United States, 53226 Argentina Hospital Italiano de Buenos Aires Buenos Aires, Argentina Less <<
NCT02471313 Liver Cancer ... More >>Liver Neoplasm Hepatocellular Carcinoma HCC Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00769730 - Completed - Taiwan ... More >> Kaohsiung Medical University Hospital Kaohsiung, Taiwan, 807 Less <<
NCT00834028 - Completed - Taiwan ... More >> Kaohsiung Medical University Hospital Kaohsiung, Taiwan, 807 Less <<
NCT00261378 Primary Liver Cancer Phase 2 Completed - Austria ... More >> Medizinische Universitat Innsbruck Innsbruck, Austria, 6020 Allgemines Krankenhaus Vienna Vienna, Austria, 1090 France L'Hopital Beaujon Clichy, France, 92100 Hopital Claude Huriez Lille, France, 59037 Groupement Hospitalier Edouard Herriot Lyon, France, 69437 Hopital Archet II Nice, France, 6200 Hopital Pitie Salpetriere Paris, France, 75013 CHU Rangueil Toulouse, France, 31059 Institut Gustave Roussy Villejuif, France, 94805 Germany Klinikum der Johann-Wolfgang-Goethe-Universitat Frankfurt am Main, Germany, 60590 Medicinische Hochschule Hannover Hannover, Germany, 30625 Klinikum der Johannes Guttenberg Mainz, Germany, 55131 Fakultat fur Klinische Medizin Mannheim Universitat Mannheim, Germany, 68167 Switzerland Inselspital Bern Bern, Switzerland, 3010 Hopitaux Universitaires de Geneve Geneve, Switzerland, 3010 Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, 1011 Universitatsspital Zurich Zurich, Switzerland, 8091 Less <<
NCT02724540 Adults With Unresectable Liver... More >>-dominant Neuroendocrine Tumor Metastases That Are Are Symptomatic, Progressive, or Involve 25% of the Liver Volume Less << Phase 2 Recruiting March 2021 United States, California ... More >> University of California San Francisco Recruiting San Francisco, California, United States, 94143 Contact: Nicholas Feldman, MD          Principal Investigator: Nicholas Feldman, MD          Stanford University Recruiting Stanford, California, United States, 94305 Contact: Nishita Kothary, MD          Principal Investigator: Nishita Kothary, MD          United States, Florida Moffitt Cancer Center Recruiting Tampa, Florida, United States, 33612 Contact: Ghassan El-Haddad, MD          Principal Investigator: Ghassan El-Haddad, MD          United States, Louisiana Ochsner Medical Center Recruiting Baton Rouge, Louisiana, United States, 70816 Contact: Juan Gimenez, MD          Principal Investigator: Juan Gimenez, MD          United States, Oregon Oregon Health & Science University Recruiting Portland, Oregon, United States, 97239 Contact: Kenneth Kolbeck, MD, PhD          Principal Investigator: Kenneth Kolbeck, MD, PhD          United States, Pennsylvania Hospital of the University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Michael C Soulen, MD, FSIR    855-216-0098    michael.soulen@uphs.upenn.edu    Principal Investigator: Michael C Soulen, MD, FSIR          United States, Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Rony Avritscher, MD          Principal Investigator: Rony Avritscher, MD          United States, Wisconsin Medical College of Wisconsin Recruiting Milwaukee, Wisconsin, United States, 53226 Contact: Sarah B White, MD, MS          Principal Investigator: Sarah B White, MD, MS          Argentina Hospital Italiano de Buenos Aires Recruiting Buenos Aires, Argentina, C1191 ABH Contact: Ricardo Monaco-Garcia, MD          Principal Investigator: Ricardo Monaco-Garcia, MD Less <<
NCT02525380 Hepatocellular Carcinoma Phase 4 Active, not recruiting August 2018 Korea, Republic of ... More >> Seoul National University Seoul, Korea, Republic of, ASI|KR|KS013 Less <<
NCT01229839 Hepatocellular Carcinoma Phase 3 Unknown August 2018 China, Guangdong ... More >> Cancer Center Sun Yat-sen University Recruiting Guangzhou, Guangdong, China Contact: Ming Shi, MD    86-2087343582 ext 86-2087343582    shiming@mail.sysu.edu.cn    Contact: Rong Ping Guo, MD    86-2087343117 ext 86-2087343117    guorongp@mail.sysu.edu.cn    Principal Investigator: Ming Shi, MD Less <<
NCT03235167 Hepatocellular Carcinoma Phase 1 Not yet recruiting October 2022 -
NCT02787954 - Terminated(PI transferred to a... More >>nother institution and did not take this study with him.) Less << - United States, Texas ... More >> University of Texas Health Science Center Houston Houston, Texas, United States, 77030 Less <<
NCT03299036 Cancer of Liver Not Applicable Completed - Taiwan ... More >> National Cheng Kung University Hospital Tainan, Taiwan Less <<
NCT01327521 Carcinoma, Hepatocellular Phase 3 Withdrawn(Accrual below target... More >> levels) Less << - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT03697044 - Not yet recruiting January 2024 United Kingdom ... More >> The Christie Hospital NHS Foundation Trust Not yet recruiting Manchester, United Kingdom, M204BX Contact: Damian Mullan, MD    00441614463000 ext 2498    damian.mullan@christie.nhs.uk    Contact: Jon Bell, MD    00441614463000 ext 3325    jon.bell@christie.nhs.uk    Principal Investigator: Damian Mullan, MD          Sub-Investigator: Jon Bell, MD          Sub-Investigator: Pavan Najran, MD Less <<
NCT02251353 - Recruiting June 2022 Turkey ... More >> Istanbul University Istanbul Medical Faculty Recruiting Istanbul, Turkey Contact: Vahit Ozmen, MD          Sub-Investigator: Abdullah Igci, MD          Sub-Investigator: Mahmut Muslumanoglu, MD          Sub-Investigator: Neslihan Cabioglu, MD Less <<
NCT00109954 Liver Cancer Phase 3 Completed - United States, Pennsylvania ... More >> Hillman Cancer Center at University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT03213314 Liver Cancer ... More >>Surgery Liver Regeneration Colorectal Cancer Metastatic Less << Not Applicable Recruiting December 31, 2019 United Kingdom ... More >> Hampshire Hospitals Foundation Trust Recruiting Basingstoke, United Kingdom Contact: Joanne McClintock          NHS Lothian Royal Infirmary of Edinburgh Recruiting Edinburgh, United Kingdom Contact: Damian J Mole Less <<
NCT03743675 Overweight and Obesity ... More >> Inflammation; Muscle Sedentary Lifestyle Less << Not Applicable Recruiting September 30, 2021 United States, Ohio ... More >> Miami University, Department of Kinesiology and Health, Phillips Hall Recruiting Oxford, Ohio, United States, 45056 Contact: Anita Sackenheim    513-529-2700    sackenac@miamioh.edu Less <<
NCT02638857 Recurrence Hepatocellular Carc... More >>inoma Advanced Hepatocellular Carcinoma Less << Phase 1 Phase 2 Unknown September 2017 China ... More >> Eastern Hepatobiliary Surgery Hospital Recruiting Shanghai, China, 200438 Contact: Huajun Jin, phd    +86-21-81875372    hj-jin@hotmail.com    Principal Investigator: Feng Shen, PHD          Principal Investigator: Qijun Qian, PHD          Principal Investigator: Zengqiang Qu, PHD          Principal Investigator: Qian Zhang, PHD          Principal Investigator: Huajun Jin, PHD          Sub-Investigator: Yao Huang, PHD          Sub-Investigator: Yan Sun, PHD          Sub-Investigator: Fuping Zhou, PHD Less <<
NCT00999843 Hepatocellular Carcinoma Phase 1 Phase 2 Unknown October 2012 China, Shanghai ... More >> Fudan University Shanghai Cancer Center Recruiting Shanghai, Shanghai, China, 200032 Less <<
NCT03086096 - Recruiting March 2022 Austria ... More >> CIRSE Cardiovascular and Interventional Radiological Society of Europe Recruiting Vienna, Austria, 1010 Contact: Robert Bauer, MA    +43 1 904 2003 ext 37    bauer@cirse.org    Contact: Nathalie Kaufmann, MSc    +43 1 904 2003 ext 53    kaufmann@cirse.org Less <<
NCT02585479 Hepatocellular Carcinoma Phase 2 Phase 3 Unknown October 2017 -
NCT01010984 Stage IV Melanoma Not Applicable Completed - United States, Kentucky ... More >> University of Louisville Louisville, Kentucky, United States, 40202 United States, Pennsylvania Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77230 Less <<
NCT02724332 Hepatocellular Carcinoma ... More >> Rapamycin Less << Phase 1 Completed - China, Shanghai ... More >> Eastern hepatobilliary surgery hospital Shanghai, Shanghai, China, 200438 Less <<
NCT00293397 - Completed - -
NCT01792934 Multi-organ Metastatic Colorec... More >>tal Cancer Less << Not Applicable Recruiting December 2020 Netherlands ... More >> Noordwest Ziekenhuis Groep Recruiting Alkmaar, Netherlands Contact: MP Hendriks, Dr          Principal Investigator: MP Hendriks, Dr          Ziekenhuisgroep Twente Recruiting Almelo, Netherlands Contact: R Hoekstra, R          Principal Investigator: R Hoekstra, R          Meander Medisch Centrum Recruiting Amersfoort, Netherlands Contact: HJ Bloemendal, HJ          Principal Investigator: HJ Bloemendal, Dr          Amstelveen Ziekenhuis Recruiting Amstelveen, Netherlands Contact: AA van Zweeden, Drs          Principal Investigator: AA van Zweeden, Drs          VU Medical Center Recruiting Amsterdam, Netherlands, NL-1081 HV Contact: H.M.W. Verheul, MD, PhD    0031-20-4444321    h.verheul@vumc.nl    Principal Investigator: H.M.W. Verheul, MD, PhD          Academisch Medisch Centrum Recruiting Amsterdam, Netherlands Contact: PJ Tanis, Dr          Principal Investigator: PJ Tanis, Dr          Onze Lieve Vrouwe Gasthuis Not yet recruiting Amsterdam, Netherlands Contact: JM Meerum Terwogt, Dr          Principal Investigator: JM Meerum Terwogt, Dr          Amphia Ziekenhuis Recruiting Breda, Netherlands Contact: A Ten Tije, Dr          Principal Investigator: A Ten Tije, Dr          Medisch Centrum Haaglanden Recruiting Den Haag, Netherlands Contact: HH Helgason, Dr          Principal Investigator: HH Helgason, Dr          Deventer Ziekenhuis Recruiting Deventer, Netherlands Contact: H Torrenga, Dr          Principal Investigator: H Torrenga, Dr          Albert Schweizer ziekenhuis Recruiting Dordrecht, Netherlands Contact: M Trajkovic, MD          Principal Investigator: M Trajkovic, MD          Maxima Medisch Centrum Recruiting Eindhoven, Netherlands Contact: G Vreugdenhil, Dr          Principal Investigator: G Vreugdenhil, Dr          Universitair Medisch Centrum Groningen Recruiting Groningen, Netherlands Contact: GAP Hospers, Prof Dr          Principal Investigator: GAP Hospers, Dr          Spaarne ziekenhuis Recruiting Hoofddorp, Netherlands Contact: A Beeker, Drs.          Principal Investigator: A Beeker, Drs          Medisch Centrum Leeuwarden Recruiting Leeuwarden, Netherlands Contact: M Polee, Dr          Principal Investigator: M Polee, Dr          Academisch ziekenhuis Maastricht Recruiting Maastricht, Netherlands Contact: RLH Jansen, Dr          Principal Investigator: RLH Jansen, Dr          Sint Antonius Ziekenhuis Recruiting Nieuwegein, Netherlands Contact: M Los, Dr          Principal Investigator: M Los, Dr          UMC Sint Radboud Recruiting Nijmegen, Netherlands Contact: SA Radema, Dr          Principal Investigator: SA Radema, Dr          Bravis ziekenhuis Recruiting Roosendaal, Netherlands Contact: Troost          Principal Investigator: Troost          Erasmus University Medical Center Recruiting Rotterdam, Netherlands, NL-3075 EA Contact: C. Verhoef, MD PhD    0031 (0)10 7040704    c.verhoef@erasmusmc.nl    Principal Investigator: C. Verhoef, MD PhD          Franciscus Gasthuis Recruiting Rotterdam, Netherlands Contact: P Hamberg, Dr          Principal Investigator: P Hamberg, Dr          IJsselland ziekenhuis Recruiting Rotterdam, Netherlands Contact: Vermaas          Principal Investigator: Vermaas          Maasstadziekenhuis Recruiting Rotterdam, Netherlands Contact: TC Kok, Dr          Principal Investigator: TC Kok, Dr          Elisabeth Tweesteden Ziekenhuis Recruiting Tilburg, Netherlands Contact: L Beerepoot, Dr          Principal Investigator: L Beerepoot, Dr          Diakonessenhuis Utrecht Recruiting Utrecht, Netherlands Contact: D Ten Bokkel Huinink, Dr          Principal Investigator: D Ten Bokkel Huinink, Dr          Universitait Medisch Centrum Utrecht Not yet recruiting Utrecht, Netherlands Contact: IHM Borel Rinkes, Prof Dr          Principal Investigator: IHM Rinkes, IHM          Admiraal de Ruyter Hospital Recruiting Vlissingen, Netherlands Contact: van Halteren          Principal Investigator: van Halteren          Jeroen Bosch Ziekenhuis Not yet recruiting Zaltbommel, Netherlands Contact: JFM Pruijt, Dr          Principal Investigator: JFM Pruijt, Dr          Isala Klinieken Recruiting Zwolle, Netherlands Contact: JWB de Groot, Dr          Principal Investigator: JWB de Groot, Dr Less <<
NCT01891539 - Unknown December 2017 Italy ... More >> Azienda Ospedaliera Ospedali Riuniti Marche Nord, Presidio Ospedaliero San Salvatore Recruiting Pesaro, PU, Italy, 61122 Contact: Giammaria Fiorentini, MD    +390721364124    giammaria.fiorentini@ospedalimarchenord.it    Principal Investigator: Giammaria Fiorentini, MD Less <<
NCT01010984 - Completed - -
NCT02755311 Hepatocellular Carcinoma Phase 3 Unknown June 2016 China, Guangdong ... More >> The First Affiliated Hospital of Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510080 Contact: Zhenwei Peng, MD       pengzhenwei2005@163.com Less <<
NCT00293397 Liver Cancer Not Applicable Completed - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT01324076 Liver Cancer Phase 3 Unknown - United Kingdom ... More >> Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust Recruiting Birmingham, England, United Kingdom, B15 2TH Contact: Contact Person    44-121-472-1311       Bristol Royal Infirmary Recruiting Bristol, England, United Kingdom, BS2 8HW Contact: Contact Person    44-117-923-0000       Aintree University Hospital Recruiting Liverpool, England, United Kingdom, L9 7AL Contact: Contact Person    44-151-525-5980       Royal Free Hospital Recruiting London, England, United Kingdom, NW3 2QG Contact: Contact Person    44-20-7794-0500       King's College Hospital Recruiting London, England, United Kingdom, SE5 9RS Contact: Contact Person    44-20-3299-9000       Royal Marsden - London Recruiting London, England, United Kingdom, SW3 6JJ Contact: Contact Person    44-20-7352-8171       Queen's Medical Centre Recruiting Nottingham, England, United Kingdom, NG7 2UH Contact: Contact Person    44-115-924-9924       Southampton General Hospital Recruiting Southampton, England, United Kingdom, SO16 6YD Contact: Contact Person    44-23-8079-8751 Less <<
NCT02862587 Precision Cells ... More >> Chemotherapy Advanced Lung Cancer Less << Phase 1 Phase 2 Unknown August 2018 China, Shanghai ... More >> Shanghai International Medical Center Recruiting Shanghai, Shanghai, China, 201318 Contact: Naiyan Han    +86 (0) 182 1766 2469    naiyan.han@simcgroup.com Less <<
NCT01259024 Hepatocellular Carcinoma Not Applicable Terminated(inability to obtain... More >> CMS approval) Less << - United States, Missouri ... More >> Barnes-Jewish Hospital/Washington Univesity School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT02729506 Hepatocellular Carcinoma Phase 4 Unknown December 2017 Saudi Arabia ... More >> King Faisal Specilist Hopsital & Researchc Center Recruiting Riyadh, Saudi Arabia, 11211 Contact: Mohamed I Al Sebayel, Prof       msebayel@kfshrc.edu.sa    Sub-Investigator: Hamad AlSuhaibani, MD, FRCP          Sub-Investigator: Faisal Aba AlKhail, MD          Sub-Investigator: Ahmad M Al Zahrani, MD          Sub-Investigator: Hussien A Elsiesy, MD Less <<
NCT01676194 Hepatocellular Carcinoma Phase 3 Active, not recruiting December 2018 France ... More >> Hôpital Henri Mondor - Assistance Publique-Hôpitaux de Paris Créteil, France, 94010 Hôpital Michalon, CHU de Grenoble Grenoble, France, 38000 Hôpital Claude Huriez, CHU de Lille Lille, France, 59000 Hôpital de la Croix Rousse, HCL, Lyon Lyon, France, 69000 Hôpital Saint-Antoine / APHP Paris, France, 75000 Hôpital Pontchaillou Rennes, France, 35033 Hôpital Trousseau, CHU de Tours Tours, France, 37000 Less <<
NCT01259024 - Terminated(inability to obtain... More >> CMS approval) Less << - -
NCT01011010 Liver Cancer Phase 1 Completed - United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 Less <<
NCT01004978 Hepatocellular Carcinoma ... More >> Unresectable Hepatocellular Carcinoma Less << Phase 3 Active, not recruiting - -
NCT01281683 - Unknown - Taiwan ... More >> National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Tiffany Ting-Fang Shih, MD    886-223123456 ext 65568    ttfshih@ntu.edu.tw Less <<
NCT02525952 Hepatocellular Carcinoma Not Applicable Unknown December 2017 China, Shanghai ... More >> Eastern hepatobilliary surgery hospital Recruiting Shanghai, Shanghai, China, 200438 Contact: Yong Xia, Doctor    86-021-81875495       Eastern hepatobilliary surgery hospital Recruiting Shanghai, Shanghai, China, 200438 Contact: Shen Feng, MD    0086-021-25070805    shenfengdfgd@yahoo.com.cn    Contact: Wu Dong, MD    0086-021-25070765    wuyuz@yahoo.com.cn    Principal Investigator: Shen Feng, MD Less <<
NCT00739167 - Completed - United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611-3013 Less <<
NCT02821754 Biliary Tract Neoplasms ... More >> Liver Cancer Hepatocellular Carcinoma Cholangiocarcinoma Bile Duct Cancer Less << Phase 2 Recruiting April 30, 2021 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT02372162 - Active, not recruiting July 2019 Germany ... More >> University Hospital Tuebingen, BW, Germany, D-72076 Less <<
NCT02138981 Resectable Hepatocellular Carc... More >>inoma Beyond Milan Criteria Less << Phase 4 Recruiting August 2020 China, Guangdong ... More >> Cancer Center Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Ming Shi, MD    86-2087343115    shiming@mail.sysu.edu.cn    Principal Investigator: Ming Shi, MD Less <<
NCT02994251 Unresectable Intrahepatic Chol... More >>angiocarcinoma Less << Phase 2 Recruiting June 2020 United States, Connecticut ... More >> Smilow Cancer Center Recruiting New Haven, Connecticut, United States, 06510 Contact: Todd Schlachter, MD    203-785-4747    todd.schlachter@yale.edu    Sub-Investigator: Hyun Kim, MD          Sub-Investigator: Stacey Stein, MD          Sub-Investigator: Howard S Hochster, MD          Sub-Investigator: Jill Lacy, MD          Sub-Investigator: Jeffrey Pollak, MD Less <<
NCT03059238 Liver Cancer ... More >>Pain Postoperative Less << Phase 3 Recruiting December 2019 China, Guangdong ... More >> Minimally Invasive Interventional Division, Department of Medical Imaging and Interventional Radiology, Sun Yat-sen University Cancer Center, Recruiting Guangzhou, Guangdong, China, 500060 Contact: Ming Zhao, MD    86-20-87343272    zhaoming@sysucc.org.cn Less <<
NCT00630240 - Completed - Taiwan ... More >> Division of Hepatobiliary Medicine, Department of Internal Medicine, Kaohsiung Medical University Hospital, No. 100 Tzyou 1st Road Kaohsiung, Taiwan, 807 Less <<
NCT03494946 Liver Metastases ... More >> Colorectal Cancer Less << Not Applicable Recruiting January 2027 Norway ... More >> Oslo University Hospital Recruiting Oslo, Norway Contact: Svein Dueland, PhD    +4722934000    svedue@ous-hf.no    Contact: Maria Gjerde    +4723070000    mgjerde@ous-hf.no Less <<
NCT03175016 Colon Cancer Liver Metastasis Phase 2 Phase 3 Recruiting December 2019 China, Tianjin ... More >> Tianjin Medical University Cancer Institute and Hospital Recruiting Tianjin, Tianjin, China, 300060 Contact: Zhi Guo, MD    13920076145    cjr.guozhi@vip.163.com    Contact: Xueling Yang, MD    15620930669    yxueling123@163.com    Sub-Investigator: Wenge Xing Less <<
NCT01259414 Hepatocellular Carcinoma Phase 3 Unknown January 2017 China, Guangdong ... More >> Cancer Center Sun Yat-sen University Recruiting Guangzhou, Guangdong, China Contact: Ming Shi    86-2087343582 ext 86-2087343582    shiming@mail.sysu.edu.cn    Contact: Ping Rong Guo    86-2087343117 ext 86-2087343117    guorongp@mail.sysu.edu.cn    Principal Investigator: Ming Shi Less <<
NCT02568748 Liver Cancer Phase 3 Recruiting October 2019 Egypt ... More >> Sherief Abd-Elsalam Recruiting Cairo, Tanta, Egypt Contact: Sherief Abd-elsalam, lecturer    00201000040794    Sherif_tropical@yahoo.com    Sub-Investigator: Ahmed Elsharkawy, Ass. lect. Less <<
NCT00805896 Hepatocellular Carcinoma ... More >> Unresectable Less << Phase 2 Unknown December 2010 China, Shanghai ... More >> Cancer Hospital of Fudan University Shanghai, Shanghai, China, 200032 Liver Cancer Institute and Zhongshan Hospital Shanghai, Shanghai, China, 200032 Less <<
NCT01060423 Colorectal Cancer Phase 2 Terminated(Terminated due to p... More >>oor subject enrolment) Less << - Germany ... More >> Zentralklinik Bad Berka GmbH, Abteilung für Interventionelle Radiologie Bad Berka, Germany, 99437 Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden Dresden, Germany, 01307 Kliniken Essen-Mitte, Klinik für Innere Medizin IV Essen, Germany, 45136 Klinikum Esslingen, Klinik für Onkologie, Gastroenterologie und Allgemeine Innere Medizin Esslingen, Germany, 73730 Krankenhaus Nordwest Frankfurt/M., Germany, 60488 Universitätsklinikum der Johann Wolfgang Goethe Universität Frankfurt Frankfurt/M., Germany, 60590 Martin-Luther-Universität Halle-Wittenberg Halle (Saale), Germany, 06097 Universitätsklinikum Hamburg-Eppendorf Hamburg, Germany, 20246 SLK-Kliniken Heilbronn Heilbronn, Germany, 74078 Otto-von-Guericke-Universität Magdeburg Magdeburg, Germany, 39120 Universitätsklinikum Regensburg Regensburg, Germany, 93053 Universitätsklinikum Tübingen, Medizinische Klinik und Poliklinik II Tübingen, Germany, 72076 Universitätsklinikum Würzburg, Institut für Röntgendiagnostik Würzburg, Germany, 97080 Less <<
NCT00817895 Hepatocellular Carcinoma Not Applicable Completed - China, Shanghai ... More >> Eastern Hepatobiliary Surgery Hospital Shanghai, Shanghai, China, 200438 Less <<
NCT02552745 - Completed - -
NCT01920503 - Recruiting August 2020 Italy ... More >> Azienda Ospedaliera Ospedali Riuniti Marche Nord, Presidio Ospedaliero San Salvatore Recruiting Pesaro, Italy, 61122 Contact: Giammaria Fiorentini, MD    +39072136 ext 4124    giammaria.fiorentini@ospedalimarchenord.it    Principal Investigator: Giammaria Fiorentini, MD Less <<
NCT01618253 Hepatocellular Carcinoma ... More >> Hepatocellular Cancer Hepatoma Liver Cancer Less << Phase 1 Withdrawn(Closed due to poor a... More >>ccrual.) Less << June 2016 United States, Wisconsin ... More >> Froedtert Memorial Lutheran Hospital Milwaukee, Wisconsin, United States, 53226 Less <<
NCT03614546 Primary Hepatocellular Carcino... More >>ma Less << Not Applicable Recruiting July 30, 2021 China, Hunan ... More >> The Third Xiangya Hospital, Central South University Recruiting Changsha, Hunan, China, 410013 Contact: xi zhang, doctor    86-13787318097    flash_z@126.com    Contact: zewen song, doctor    86-18374800202    thomasze2007@163.com    Principal Investigator: peiguo cao, doctor          Sub-Investigator: xi zhang, doctor          Sub-Investigator: zewen song, doctor Less <<
NCT02853500 Liver Cancer Not Applicable Recruiting July 2022 United States, Massachusetts ... More >> Brigham and Women's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Dmitry Rabkin, MD, PhD    617-732-4763    drabkin@partners.org    Principal Investigator: Dmitry Rabkin, MD, PhD Less <<
NCT00493402 Hepatocellular Carcinoma Phase 3 Completed - China, Guangdong ... More >> Cancer Center Sun Yat-sen University Guangzhou, Guangdong, China, 510060 Less <<
NCT02964260 Hepatocellular Carcinoma, Adul... More >>t Less << Not Applicable Recruiting December 2022 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Jinhua Huang, Ph.D    0086-20-87343447       Principal Investigator: Jinhua Huang, Ph.D Less <<
NCT00479050 Hepatocellular Carcinoma Phase 1 Completed - -
NCT02854839 Hepatocellular Carcinoma Phase 2 Recruiting June 2018 Korea, Republic of ... More >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 03080 Contact: Jung-Hwan Yoon, MD, PHD          Seoul Asan Medical center Active, not recruiting Seoul, Korea, Republic of, 05505 Samsung Medical Center Recruiting Seoul, Korea, Republic of, 06351 Contact: Joon Hyeok Lee, MD, PhD Less <<
NCT02007954 - Completed - -
NCT01894269 Hepatocellular Carcinoma Phase 4 Unknown July 2016 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Xiang-Ming Lao, MD    8620-87343114    laoxming@mail.sysu.edu.cn Less <<
NCT01901692 Hepatocellular Carcinoma Phase 2 Phase 3 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 05505 Less <<
NCT02007954 Hepatocellular Carcinoma Phase 2 Completed - United States, Maryland ... More >> The Johns Hopkins Hospital Baltimore, Maryland, United States, 21287 Less <<
NCT02678806 HepatoCellular Carcinoma Not Applicable Recruiting November 1, 2022 China, Guangxi ... More >> TaoBai Recruiting Nanning, Guangxi, China, 530000 Contact: Bai Tao, MD    +86 13878862632    25859373@qq.com Less <<
NCT01872988 Chronic Hepatitis B ... More >> Hepatocellular Carcinoma Less << Phase 3 Terminated(Difficult in patien... More >>t enrollment) Less << February 2018 Taiwan ... More >> Chia-Yi Christine Hospital Chia-Yi, Taiwan, 539 E-Da Hospital Kaohsiung, Taiwan, 824 Taichung Veterans General Hospital Taichung, Taiwan, 407 Mackay Memorial Hosp Taipei, Taiwan, 104 Less <<
NCT02929082 Hepatocellular Cancer Not Applicable Recruiting December 2019 France ... More >> Valérie Vilgrain Recruiting Clichy, France, 92110 Contact: valerie Vilgrain Less <<
NCT01798134 Hepatocellular Carcinoma Not Applicable Completed - Germany ... More >> Klinikum der Universitat Heidelberg Heidelberg, Baden-Wuerttemberg, Germany, 69120 SLK-Kliniken Heilbronn GmbH Heilbronn, Baden-Wuerttemberg, Germany, 74078 Klinikum Stuttgart- Katharinenhospital Stuttgart, Baden-Wuerttemberg, Germany, 70174 Klinikum Bogenhausen Munchen, Bayern, Germany, 81925 Kilinikum Darmstadt Darmstadt, Hessen, Germany, 64283 Universitatsklinikum Essen Essen, Nordrhein-Westfalen, Germany, 45147 University Hospital Regensburg Regensburg, Germany, 93042 Less <<
NCT02013778 Hepatocellular Carcinoma Phase 1 Phase 2 Recruiting - United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Gregory Nadolski, MD    855-216-0098    PennCancerTrials@emergingmed.com    Principal Investigator: Gregory Nadolski, MD Less <<
NCT02015754 Colorectal Cancer Phase 2 Completed - United States, Maryland ... More >> The Johns Hopkins Hospital Baltimore, Maryland, United States, 21287 Less <<
NCT02015754 - Completed - -
NCT01409499 Hepatectomy H... More >>epatocellular Carcinoma Sorafenib Less << Phase 4 Completed - China, Guangdong ... More >> Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China, 510060 Less <<
NCT02221778 Carcinoma, Hepatocellular Phase 2 Recruiting July 2020 Brazil ... More >> Instituto do Cancer do Estado de Sao Paulo, Hospital das Clinicas da Faculdade de Medicina da USP Recruiting Sao Paulo, Brazil, 01246000 Contact: Luciana O Kikuchi, MD       lucianakikuchi29@gmail.com    Contact: Andre T Chen, MD    38934540    andre.chen@hc.fm.usp.br    Principal Investigator: Andre T Chen, MD          Sub-Investigator: Karina Moutinho, MD Less <<
NCT02061956 - Completed - China, Guangdong ... More >> Cancer Center, Sun Yat-sen University Guangzhou, Guangdong, China, 510060 Less <<
NCT00857805 Carcinoma, Hepatocellular Not Applicable Recruiting January 2018 United States, California ... More >> Loma Linda University Medical Center Recruiting Loma Linda, California, United States, 92354 Less <<
NCT01387932 Hepatocellular Carcinoma Phase 3 Active, not recruiting December 2022 -
NCT02125396 Hepatocellular Carcinoma Phase 3 Recruiting June 2018 China, Guangxi ... More >> Department of Hepatobilliary Surgery, Affiliated Tumor of Guangxi University Recruiting Nanning, Guangxi, China, 530021 Contact: Jian-Hong Zhong, MD    86-771-5330855    zhongjianhong66@163.com    Principal Investigator: Jian-Hong Zhong, MD Less <<
NCT01798134 - Completed - -
NCT01318200 Recurrent Hepatocellular Carci... More >>noma Less << Phase 3 Withdrawn February 2016 United States, California ... More >> Stanford Comprehensive Cancer Center Stanford, California, United States, 94305 Less <<
NCT03722498 Hepatocellular Carcinoma Phase 2 Recruiting November 1, 2018 China, Guangdong ... More >> Ming Shi Recruiting Guangzhou, Guangdong, China Contact: Ming Shi, MD    (8620)-87343938    shiming@sysu.edu.cn    Principal Investigator: Ming Shi, MD Less <<
NCT00335829 - Completed - -
NCT00730483 - Terminated(High incidence of b... More >>iloma and liver abscess after TACE) Less << - -
NCT01381211 Hepatocellular Carcinoma Phase 2 Unknown December 2016 Belgium ... More >> University Hospital Ghent Recruiting Ghent, Belgium, 9000 Contact: L Defreyne, PhD, MD    (0)9/332 2938 ext +32    luc.defreyne@ugent.be    Principal Investigator: L Defreyne, PhD, MD Less <<
NCT00730483 Gastrointestinal Carcinoid Tum... More >>or Islet Cell Tumor Metastatic Cancer Less << Not Applicable Terminated(High incidence of b... More >>iloma and liver abscess after TACE) Less << - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT02856815 Carcinoma, Hepatocellular Phase 2 Recruiting September 2019 Korea, Republic of ... More >> Seoul St.Mary's Hospital Not yet recruiting Seoul, Banpo-daero 222 / Seocho-go, Korea, Republic of, 06591 Contact: Si-Hyun Bae, MD    82-2-2258-7533    baesh@catholic.ac.kr    Seoul National University Hospital Recruiting Seoul, Daehak-ro 101/Jongno-gu, Korea, Republic of, 03080 Contact: Jung Hwan Yoon, MD    82-2-2072-2228    yoonjh@snu.ac.kr    Principal Investigator: Jung Hwan Yoon, MD          Severance Hospital Not yet recruiting Seoul, Seoul,50-1 Yonsei-ro/Seodaemun-gu, Korea, Republic of, 03722 Contact: Do Young Kim, MD       DYK1025@yuhs.ac Less <<
NCT01326390 - Terminated - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT00335829 Liver Cancer Phase 2 Completed - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT02716571 Healthy Volunteers Not Applicable Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of, 03080 Less <<
NCT01911000 Carcinoma. Hepatocellular Phase 2 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 Less <<
NCT00280007 Hepatocellular Carcinoma Phase 2 Terminated(Safety concerns in ... More >>the treatment arm) Less << December 2010 Austria ... More >> Medizinische Universität Wien Vienna, Austria, A-1090 Less <<
NCT01539018 Advanced Hepatocellular Carcin... More >>oma Less << Phase 2 Terminated(After interim resul... More >>ts data showed no evidence of a difference between both groups) Less << - Egypt ... More >> Ain shams university Cairo, Egypt Cairo University Hospitals Cairo, Egypt National cancer institute Cairo, Egypt NHTMRI Cairo, Egypt National Liver Institute Monofeiya, Egypt Less <<
NCT00357474 Hepatocellular Carcinoma Phase 3 Completed - Korea, Republic of ... More >> Seoul NUH Seoul, Chongno-gu, Korea, Republic of, 110-744 Less <<
NCT01352728 Hepatocellular Carcinoma Phase 2 Completed - Hong Kong ... More >> Department of Clinical Oncology, Prince of Wales Hospital Hong Kong, Hong Kong Less <<
NCT03191123 Carcinoma, Hepatocellular ... More >> Survival Rate Less << Not Applicable Recruiting July 5, 2019 China, Hubei ... More >> Hepatic surgery center, Tong ji Hospital Recruiting Wuhan, Hubei, China, 430030 Contact: Xiaoping Chen, Doctor    8602783662851    chenxp@medmail.com.cn    Contact: Ganxun Li, Doctor    8615271899935    liganxun@hust.edu.cn    Principal Investigator: peng zhu, doctor Less <<
NCT02908165 Hepatocellular Carcinoma Phase 2 Withdrawn(A future study will ... More >>be taking place using the same patient population.) Less << June 2020 United States, Connecticut ... More >> Smilow Cancer Center New Haven, Connecticut, United States, 06510 Less <<
NCT01877187 Liver Cancer Phase 2 Active, not recruiting March 2019 United States, Connecticut ... More >> Smilow Cancer Center New Haven, Connecticut, United States, 06510 United States, Maryland The Johns Hopkins Hospital Baltimore, Maryland, United States, 21287 Less <<
NCT00082082 Carcinoma, Hepatocellular Phase 2 Completed - United States, California ... More >> California Pacific Medical Center San Francisco, California, United States, 94115 United States, Florida University of Florida Gainesville, Florida, United States, 32610 United States, Michigan William Beaumont Hospital Royal Oak, Michigan, United States, 48073 United States, New York Columbia University New York, New York, United States, 10032 United States, Virginia Metropolitan Research Fairfax, Virginia, United States, 22031 Less <<
NCT02253511 Hepatocellular Carcinoma Phase 4 Unknown July 2017 China ... More >> Eastern Hepatobiliary Surgery Hospital Recruiting Shanghai, China, 200438 Contact: Wenjie Dong, MD    8615810115565    microripple@yahoo.com Less <<
NCT03170869 Hepatocellular Carcinoma of th... More >>e Liver Subjects Eligible for Liver Transplantation Less << Not Applicable Terminated(Sponsor withdrew fu... More >>nding) Less << - United States, Colorado ... More >> University of Colorado Hospital Aurora, Colorado, United States, 80045 Less <<
NCT00956930 Liver Cancer Phase 2 Completed - United States, Illinois ... More >> Northwestern University, Northwestern Memorial Hospital Chicago, Illinois, United States, 60611-3013 Less <<
NCT01715532 Carcinoma, Hepatocellular Phase 2 Unknown June 2016 China, Shanghai ... More >> Fudan University Shanghai Cancer Center Recruiting Shanghai, Shanghai, China, 200032 Contact: Yehua Shen, MD    86-21-64175590 ext 83625    yehuash25@163.com    Principal Investigator: Hao Chen, MD Less <<
NCT03698643 - Completed - France ... More >> Uhmontpellier Montpellier, France, 34295 Less <<
NCT01102335 Hepatocellular Carcinoma Phase 4 Unknown December 2012 China, Shanghai ... More >> Liver cancer institute, Zhongshan Hospital, Fudan University Recruiting Shanghai, Shanghai, China, 200032 Contact: jinglin xia, MD          Principal Investigator: jinglin xia, MD Less <<
NCT01539993 - Completed - United States, Georgia ... More >> Emory University Atlanta, Georgia, United States, 30322 Less <<
NCT03338166 - Not yet recruiting December 2018 -
NCT00049322 Liver Cancer Phase 2 Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States, 90095-1781 Less <<
NCT00049322 - Completed - -
NCT01387503 Carcinoma, Hepatocellular ... More >> Cirrhosis Less << Phase 2 Phase 3 Unknown January 2014 Italy ... More >> Ospedali Riuniti di Bergamo Recruiting Bergamo, Italy, 24125 Ospedale Maggiore di Milano Policlinico Recruiting Milano, Italy, 20122 Istituto Nazionale Tumori Recruiting Milano, Italy, 20133 Azienda Ospedaliera Ospedale Niguarda Ca' Granda Recruiting Milano, Italy, 20162 Azienda Ospedaliera Universitaria di Padova Recruiting Padova, Italy, 35128 Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione (ISMETT) Recruiting Palermo, Italy, 90133 Policlinico Tor Vergata Recruiting Roma, Italy, 00133 Ospedale "Lazzaro Spallanzani" Recruiting Roma, Italy, 00149 Ospedale Umberto Iº Policlinico di Roma Recruiting Roma, Italy, 00161 Ospedale Universitario Molinette S. Giovanni Battista di Torino Recruiting Torino, Italy, 10126 Less <<
NCT01042041 Hepatocellular Carcinoma ... More >> Liver Cancer Localized Unresectable Liver Cancer Less << Phase 1 Completed - United States, Pennsylvania ... More >> Abramson Cancer Center of The University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00003907 Liver Cancer ... More >>Metastatic Cancer Less << Phase 2 Completed - -
NCT03452553 Hepatocellular Carcinoma (HCC) Not Applicable Withdrawn(CMS disapproval, no ... More >>alternative for sites/patient, risk of financial burden.) Less << October 30, 2020 -
NCT01657695 - Completed - Italy ... More >> Azienda Ospedaliero-Universitaria Modena, Italy, 41124 Less <<
NCT00003907 - Completed - -
NCT00825955 Liver Cancer Phase 3 Terminated(Efficacy endpoint m... More >>et, however, overall experimental dosing regimen is not considered optimal to support further clinical development in this patient population) Less << - -
NCT02548780 HCC Hepatocel... More >>lular Carcinoma Less << Not Applicable Active, not recruiting October 2018 Greece ... More >> Evgenidio Therapeftirio "Agia Trias" Athens, Greece Spain Hospital Clínic i provincial de Barcelona Barcelona, Spain Switzerland Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland Less <<
NCT01796145 Confirmed Diagnosis of Hepatoc... More >>ellular Carcinoma Patients Who Are Scheduled to Undergo Transarterial Chemobolization, Systemic Therapy Surgery Child's A to C Cirrhosis Less << Not Applicable Recruiting December 31, 2020 Hong Kong ... More >> Department of Clinical Oncology, Prince of Wales Hospital Recruiting Hong Kong, Hong Kong Contact: Stephen Lam Chan, FHKCP    3505 1042    l_chan@clo.cuhk.edu.hk    Contact: Nicole Yim, RN    3505 1046    nicole@clo.cuhk.edu.hk    Principal Investigator: Stephen Lam Chan, FHKCP Less <<
NCT01549275 - Completed - Taiwan ... More >> Kaohsiung Medical University Hospital Kaohsiung, Taiwan, 807 Less <<
NCT01315639 Alzheimer's Disease ... More >> Mild Cognitive Impairment Less << Not Applicable Active, not recruiting February 2019 France ... More >> APHP, Hôpital Broca Paris, France, 75013 Less <<
NCT00866957 - Unknown December 2018 United States, Illinois ... More >> Northwestern Memorial Hospital Recruiting Chicago, Illinois, United States, 60611 Principal Investigator: Laura Kulik, MD Less <<
NCT02990351 - Completed - -
NCT01549275 - Completed - -
NCT00830960 Acute Coronary Syndrome Phase 3 Completed - China ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China, 100853 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guang Zhou, China, 510080 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hangzhou, China, 310009 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nanjing, China, 210008 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shanghai, China, 200433 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shenyang, China, 110016 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wenzhou, China, 325027 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Xi'An, China, 710061 Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Daegu, Korea, Republic of, 700-721 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kwang Ju, Korea, Republic of, 501-757 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seongnam-Si, Korea, Republic of, 463-707 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 135 720 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Suwon-City, Korea, Republic of, 442-721 Taiwan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taichung City, Taiwan, 40201 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taichung, Taiwan, 404 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taipei, Taiwan, 112 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tao-Yuan, Taiwan, 333 Thailand For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bangkok, Thailand, 10400 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiang Mai, Thailand, 50200 Less <<
NCT01570075 Hepatocellular Carcinoma Phase 4 Unknown July 2015 China, Guangdong ... More >> Cancer Center, Sun Yat-set University Recruiting Guangzhou, Guangdong, China, 510060 Contact: min-shan chen, M.D.,Ph.D.    8620-87343117    Chminsh@mail.sysu.edu.cn    Principal Investigator: min-shan chen, M.D., Ph.D. Less <<
NCT03084380 Hepatocellular Carcinoma Phase 1 Phase 2 Not yet recruiting May 31, 2020 China, Chongqing ... More >> Department of Oncology, Xinqiao Hospital ChongQing, Chongqing, China, 400037 Less <<
NCT01473121 - Completed - Turkey ... More >> Multiple Locations, Turkey Less <<
NCT00830960 - Completed - -
NCT01821482 Hepatocellular Carcinoma (HCC) Phase 2 Unknown May 2018 China, Guangxi ... More >> The first Affiliated Hospital of Guangxi Medical University Recruiting Nanning, Guangxi, China, 530000 Contact: Hanfeng Liu    86-771-3277289       Principal Investigator: Hanfeng Liu Less <<
NCT01438450 Hepatocellular Carcinoma Phase 2 Phase 3 Unknown September 2014 India ... More >> All India Institute of Medical Sciences Recruiting New Delhi, Delhi, India, 110029 Contact: Subrat K Acharya, DM    91-112658500 ext 4934    subratacharya2004@yahoo.com Less <<
NCT02825550 Cancer of Liver Not Applicable Completed - Taiwan ... More >> National Cheng Kung University Hospital Tainan, Taiwan Less <<
NCT02066974 - Unknown February 2016 Taiwan ... More >> China Medical University Hospital Taichung, Taiwan, 404 Less <<
NCT02472249 Hepatocellular Carcinoma Phase 4 Recruiting January 2019 Canada, Ontario ... More >> Toronto General Hospital Recruiting Toronto, Ontario, Canada, M5G 2N2 Contact: Maxime Noel-Lamy, MD FRCPC    416-946-4501 ext 5054    maxime.noel-lamy@uhn.ca Less <<
NCT03533920 Hepatocellular Carcinoma Non-r... More >>esectable Less << Not Applicable Completed - Korea, Republic of ... More >> Chonnam National University Hospital Gwangju, Korea, Republic of Seoul National University Bundang Hospital Gyeonggi-do, Korea, Republic of The Catholic University of Korea, Uijeongbu ST. Mary's Hospital Gyeonggi-do, Korea, Republic of Inha University Hospital Incheon, Korea, Republic of Pusan National University Hospital Pusan, Korea, Republic of Seoul National University Hospital Seoul, Korea, Republic of Severance Hospital Seoul, Korea, Republic of The Catholic University of Korea, Seoul ST. Mary's Hospital Seoul, Korea, Republic of Less <<
NCT02825550 - Completed - -
NCT02240771 Hepatocellular Carcinoma Phase 2 Phase 3 Unknown March 2015 India ... More >> AII India Institute of Medical Sciences Recruiting New Delhi, Delhi, India, 110029 Contact: Subrat K Acharya, DM    +91-11-26594934    subratacharya2004@yahoo.com    Contact: Shalimar . ., DM    +91-9968405815    drshalimar@yahoo.com    Principal Investigator: Subrat K Acharya, DM          Sub-Investigator: Shashi B. Paul, Ph.D          Sub-Investigator: Shivanand R Gamanagatti, M.D          Sub-Investigator: Sreenivas Vishnubhatla, Ph.D Less <<
NCT02571946 Liver Neoplasm ... More >> Portal Vein Tumor Thrombosis Proton Therapy Less << Not Applicable Recruiting September 2022 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of, 135-710 Contact: Hee Chul Park, M.D., Ph.D.    82-2-3410-2612    hee.ro.park@samsung.com    Principal Investigator: Hee Chul Park, M.D., Ph.D.          Sub-Investigator: Doo Ho Choi, M.D., Ph.D.          Sub-Investigator: Jeong Il Yu, M.D.          Sub-Investigator: Won Ki Kang, M.D., Ph.D.          Sub-Investigator: Ho Yeong Lim, M.D., Ph.D.          Sub-Investigator: Young Suk Park, M.D., Ph.D.          Sub-Investigator: Joon Oh Park, M.D., Ph.D.          Sub-Investigator: Se Hoon Park, M.D., Ph.D.          Sub-Investigator: Jeeyun Lee, M.D., Ph.D. Less <<
NCT02242786 Hepatocellular Carcinoma ... More >> Spine Metastasis Less << Phase 2 Unknown - Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of, 135-710 Contact: Jong Won Park, M.D., Ph.D.    82-2-3410-2548       Sub-Investigator: Hee Chul Park, M.D., Ph.D.          Sub-Investigator: Jeong Il Yu, MD Less <<
NCT02724267 Internal Radiation ... More >> Advanced Hepatocellular Carcinoma Less << Not Applicable Completed - China, Shanghai ... More >> Eastern hepatobilliary surgery hospital Shanghai, Shanghai, China, 200438 Less <<
NCT00910572 Hepatocellular Carcinoma ... More >> Liver Cancer Less << Phase 2 Completed - Italy ... More >> Fondazione IRCCS Istituto Nazionale dei Tumori, Milano Milano, Italy, 20133 Less <<
NCT03380130 Hepatocellular Carcinoma Phase 2 Recruiting October 1, 2019 Spain ... More >> Hospital Universitario de Cruces Recruiting Baracaldo, Spain Contact: Milagros Testillano       milagros.testillanotarrero@osakidetza.eus    Hospital Clinic Recruiting Barcelona, Spain Contact: María Reig       mreig1@clinic.ub.es    Hospital Universitario 12 de Octubre Recruiting Madrid, Spain Contact: Carlos Gómez Martin    +34 913908003    cgomezmartin@salud.madrid.org    Hospital Universitario Gregorio Marañon Recruiting Madrid, Spain Contact: Ana Mª Matilla    +34 915868304       Hospital Universitario Ramon y Cajal Recruiting Madrid, Spain Contact: José Luis Lledó       joseluis.lledo@salud.madrid.org    Hospital Universitario Central de Asturias Recruiting Oviedo, Spain Contact: María Varela       oncohep.gae4@sespa.es    Clinica Universidad de Navarra Recruiting Pamplona, Spain, 31008 Contact: Mercedes Iñarrairaegui, MD    +34 948 255 400    hepatologia@unav.es    Contact: Carmen Fuertes    +34 948 255 400    hepatologia@unav.es    Hospital Universitario Donostia Recruiting San Sebastián, Spain Contact: Juan Ignacio Arenas    +34943007173       Hospital Universitario Lozano Blesa Recruiting Zaragoza, Spain Less <<
NCT00355355 Carcinoma, Hepatocellular ... More >> Liver Neoplasms Less << Phase 3 Completed - -
NCT00121914 Carcinoma, Hepatocellular Phase 3 Unknown - Austria ... More >> Universitaetsklinik fuer Innere Medizin IV / Gastroenterologie und Hepatologie Vienna, Austria, 1090 Less <<
NCT00807300 Hepatocellular Carcinoma Phase 2 Completed - Germany ... More >> Clinic of Diagnostic Radiology and Nuclear Medicine, Medical Faculty, University Magdeburg Magdeburg, Saxony-anhalt, Germany, 39120 Less <<
NCT00877071 Hepatocellular Carcinoma Phase 2 Completed - United States, Pennsylvania ... More >> UPMC Liver Cancer Center, Montefiore 7 South, 3459 Fifth Avenue Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT00312780 Albuminuria D... More >>iabetic Nephropathy Less << Phase 2 Completed - -
NCT00877071 - Completed - -
NCT00914355 Hepatocellular Carcinoma Phase 2 Active, not recruiting August 2019 Canada, Ontario ... More >> University Health Network, Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT03564405 Hepatocellular Carcinoma Non-r... More >>esectable Less << Not Applicable Completed - Korea, Republic of ... More >> Catholic University Seoul St. Mary Hospital Seoul, Korea, Republic of Less <<
NCT03253289 Carcinoma, Hepatocellular Phase 1 Recruiting May 1, 2019 United States, Texas ... More >> Baylor Clinic Recruiting Houston, Texas, United States, 77030 Contact: Brandon Smaglo, MD    713-798-3750    smaglo@bcm.edu    Baylor St. Luke's Medical Center Recruiting Houston, Texas, United States, 77030 Contact: Brando Smaglo, MD    713-798-3750    smaglo@bcm.edu    Dan L. Duncan Cancer Center at Baylor College of Medicine Recruiting Houston, Texas, United States, 77030 Contact: Clinical Trials Office - Dan L. Duncan Cancer Center at Baylor    713-798-1297 Less <<
NCT01595243 Hepatocellular Carcinoma Not Applicable Unknown February 2013 Taiwan ... More >> National Taiwan University Hospital Recruiting Taipei, Taiwan Contact: Shiow-Ching Shun, Ph.D    886-2-2312-3456 ext 88439    scshun@ntu.edu.tw Less <<
NCT00728650 - Completed - United States, Oklahoma ... More >> The University of Oklahoma College of Medicine, Tulsa - Department of Surgery Tulsa, Oklahoma, United States, 74135 Less <<
NCT01236690 Hepatoma Cino... More >>bufacin Injection Less << Phase 2 Unknown November 2013 China, Shanghai ... More >> Department of TCM, Changhai Hospital of Shanghai Recruiting Shanghai, Shanghai, China, 200433 Contact: changquan Ling, Doctor    +86 21 81873539    qiaocuixia@126.com Less <<
NCT03163186 - Completed - United States, South Carolina ... More >> Medical University of South Carolina Charleston, South Carolina, United States, 29425 Less <<
NCT03734068 - Recruiting December 2021 Italy ... More >> Antonio Nicolini Recruiting Milano, Italy Contact: Antonio Nicolini, MD    +390255035604    anicolini54@gmail.com    Contact: Giammaria Fiorentini, MD    +390721364005    g.fiorentini@alice.it    Principal Investigator: Antonio Nicolini, MD          Sub-Investigator: Giammaria Fiorentini, MD Less <<
NCT02350400 Colorectal Cancer Metastatic Phase 1 Completed - Singapore ... More >> Singapore General Hospital Singapore, Singapore, 169608 National Cancer Centre Singapore Singapore, Singapore, 169610 Less <<
NCT01891552 - Completed - Italy ... More >> Azienda Ospedaliera Ospedali Riuniti Marche Nord, Presidio Ospedaliero San Salvatore Pesaro, PU, Italy, 61122 Less <<
NCT02369692 - Terminated - France ... More >> Hôpital Européen Georges Pompidou Paris, France Less <<
NCT02452853 Hepatocellular Carcinoma Phase 2 Unknown May 2018 -
NCT01910909 Localized Non-Resectable Adult... More >> Hepatocellular Carcinoma Less << Not Applicable Recruiting October 2018 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of, 135-710 Contact: Hee Chul Park, M.D., Ph.D.    82-2-3410-2612    hee.ro.park@samsung.com    Principal Investigator: Hee Chul Park, M.D., Ph.D. Less <<
NCT01425996 Carcinoma, Hepatocellular Phase 1 Phase 2 Terminated - Taiwan ... More >> Mackay Memorial Hospital Taipei, Taiwan Taipei Veteran General Hospital Taipei, Taiwan Less <<
NCT01328223 - Unknown December 2012 Taiwan ... More >> Shang-Wen Chen Recruiting Taichung, Taiwan, 404 Contact: Shang-Wen Chen, MD    886-4-22052121 ext 7450    vincent1680616@yahoo.com.tw    Sub-Investigator: Yu-Cheng Kuo          Sub-Investigator: Ji-An Liang, MD          Li-Ching Lin Recruiting Tainan, Taiwan, 700 Contact: Li-Ching Lin, MD       liching51@yahoo.com.tw    Jeng-Fong Chiou Recruiting Taipei, Taiwan, 100 Contact: Jeng-Fong Chiou, MD;PhD       sjfchiou@xuite.net Less <<
NCT01465464 Hepatocellular Carcinoma Phase 3 Terminated - Japan ... More >> Local Institution Osaka-sayama, Osaka, Japan, 589-8511 Local Institution Chuo-ku, Tokyo, Japan, 104-0045 Local Institution Chiba, Japan, 260-8677 Korea, Republic of Local Institution Goyang-si, Gyeonggi-do, Korea, Republic of, 410-769 Local Institution JongNo-Gu, Seoul, Korea, Republic of, 110-744 Taiwan Local Institution Zhongzheng Dist., Taipei, Taiwan, 100 Less <<
NCT00652587 Hepatocellular Carcinoma ... More >> Hepatectomy Chemoembolization Less << Phase 3 Completed - China, Guangdong ... More >> Department of Hepatobilliary Surgery, Cancer Center, Sun Yat-sen University Guangzhou, Guangdong, China, 510060 Less <<
NCT03172559 Hepatocellular Carcinoma Not Applicable Not yet recruiting September 2028 -
NCT02584556 Hepatocellular Carcinoma Phase 2 Phase 3 Unknown October 2017 -
NCT00815620 - Completed - Germany ... More >> Zentralklinik Bad Berka Bad Berka, Germany, 99437 Less <<
NCT02632864 Liver Neoplasm ... More >> Proton Therapy Less << Phase 2 Recruiting November 2022 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of, 135-710 Contact: Joon Hyeok Lee, MD, PhD    82-2-3410-3409    gijhlee.lee@samsung.com    Contact: Hee Chul Park, MD, PhD    82-2-3410-2612    hee.ro.park@samsung.com    Sub-Investigator: Jeong Il Yu, MD Less <<
NCT01825824 Hepatocellular Carcinoma Phase 2 Unknown June 2017 Korea, Republic of ... More >> Inje University Haeundae Paik Hospital Busan, Korea, Republic of, 612-896 Dongnam Institute of Radiological & Medical Sciences Busan, Korea, Republic of Soon Chun Hyang University Hospital Cheonan Cheonan, Korea, Republic of Catholic University Incheon St. Mary's Hospital Incheon, Korea, Republic of Inha University Hospital Incheon, Korea, Republic of Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences Seoul, Korea, Republic of, 139-706 Soon Chun Hyang University Hospital Seoul Seoul, Korea, Republic of Less <<
NCT02764801 Hepatocellular Carcinoma ... More >> Chemoembolization, Therapeutic Less << Phase 3 Recruiting April 2020 United States, California ... More >> University of California, San Diego Recruiting La Jolla, California, United States, 92093 Contact: Yuko Kono, MD, PhD       ykono@ucsd.edu    United States, Pennsylvania Thomas Jefferson University Recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: John R Eisenbrey, PhD    215-503-5188    john.eisenbrey@jefferson.edu    United States, Tennessee Vanderbilt University Recruiting Nashville, Tennessee, United States, 37235 Contact: Daniel B Brown, MD       daniel.b.brown@vanderbilt.edu Less <<
NCT02772029 Hepatocellular Carcinoma Phase 1 Phase 2 Unknown September 2017 -
NCT02038296 Liver Cancer Phase 3 Completed - China, Guangdong ... More >> Department of Interventional Radiology; Cancer Center; Guangdong General Hospital Guangzhou, Guangdong, China, 510080 Less <<
NCT06024252 HCC NOT_YET_RECRUITING 2024-06-01 -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.63mL

0.53mL

0.26mL

13.13mL

2.63mL

1.31mL

26.26mL

5.25mL

2.63mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories